IVRS is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases.
By using animal models we are specialized in providing 3D images to:
- characterize disease progression
- follow the therapeutic effect throughout the complete experimental time frame
- the circulation and spreading of your candidate drug in the whole body and targeted organs
- monitor pharmacokinetic/pharmacodynamic of probe distribution in vivo
Management and Board
Prof. Ramin Massoumi
Chief Executive Officer
Chairman of Board
Professor of Molecular Oncology at Lund University, Sweden. Ramin holds a PhD from Lund University investigating the link between inflammation and colon cancer. Ramin has also a long experience in generation of transgenic animals and research in the field of oncology, chronic inflammation, and metabolic diseases.
Dr. Sebastian Hansson
Sebastian holds a PhD from Lund University in Molecular Biophysics with focus on structure based drug design. Sebastian further holds a scientific MBA and has founded and co-founded several companies and been working as business developer at several companies. Sebastian also has a scientific background within the fields of oncology and respiratory disease.